OR-1855 Catalog No.:M28249-C InChi: InChI=1S/C22H34O4/c1-3-5-7-9-13-17-25-21(23)19-15-11-12-16-20(19)22(24)26-18-14-10-8-6-4-2/h11-12

InChi: InChI=1S/C22H34O4/c1-3-5-7-9-13-17-25-21(23)19-15-11-12-16-20(19)22(24)26-18-14-10-8-6-4-2/h11-12

RSV604 (5 days) inhibits the growth of four laboratory strains of RSV (RSS

34)/b21-14+

CAS Number: 1610610-48-4

OR-1855 Catalog No.:M28249-C InChi: InChI=1S/C22H34O4/c1-3-5-7-9-13-17-25-21(23)19-15-11-12-16-20(19)22(24)26-18-14-10-8-6-4-2/h11-12OR 1855, an active metabolite of Levosimendan, has effect on human myometrial contractility. Levosimendan is a calcium sensitiser used in the management of acutely decompensated congestive heart failure. Product information CAS Number: 101328 85 2 Molecular Weight: 203. 24 Formula: C11H13N3O Chemical Name: (5R) 6 (4 aminophenyl) 5 methyl 2,3,4,5 tetrahydropyridazin 3 one Smiles: C[C@@H]1CC(=O)NN=C1C1C=CC(N)=CC=1 InChiKey: GDMRFHZLKNYRRO SSDOTTSWSA N